发明名称 Tri-substituted 8H-pyrido[2,3-d]pyrimidin-7-one compounds
摘要 Disclosed is a compound and process of making a compound of formula (I) and (Ia) wherein: R1 is an optionally substituted aryl or heteroaryl ring R2 is a H, alkyl, cycloalkyl, cycloalkyl alkyl, aryl, aryl alkyl, heteroaryl, heteroaryl alkyl, heterocyclic or heterocyclyl alkyl moiety or R2 - is other moieties as defined. R3 is an alkyl, cycloalkyl, cycloalkyl alkyl, aryl, aryl alkyl, heteroaryl, heteroaryl alkyl, heterocyclyl, or an optionally substituted heterocyclyl alkyl moiety. X is R2, OR2, S(O)mR2, (CH2)nN(R10)C(O)R2, (CH2)nNR4R14 or (CH2)nN(R2)2; provided X is not hydrogen and where R4, R10, R14, R20, n and m are as defined. The compound is also disclosed for use in treating a CSBP/RK/p38 kinase mediated disease and for treating respiratory viral infections as defined.
申请公布号 NZ524806(A) 申请公布日期 2006.03.31
申请号 NZ20010524806 申请日期 2001.10.23
申请人 SMITHKLINE BEECHAM CORPORATION 发明人 ADAMS, JERRY L;BOEHM, JEFFREY C;HALL, RALPH;JIN, QI;KASPAREC, JIRI;SILVA, DOMINGOS J;TAGGART, JOHN J
分类号 A61K31/519;A61P1/04;A61P3/10;A61P7/00;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P19/00;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P25/00;A61P27/02;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/12;A61P31/14;A61P31/16;A61P35/00;A61P37/06;A61P43/00;C07D239/46;C07D239/47;C07D471/04;(IPC1-7):A61K31/505;A61K31/00;C07D239/02;C07D471/02;C07D239/28 主分类号 A61K31/519
代理机构 代理人
主权项
地址